Home Your basket
• Salvage composite resecti...
   Price 10.50 €
• Surgical management of pa...
   Price 10.50 €
• Sinonasal hemangiopericyt...
   Price 8.50 €
• A rare tumor of the parap...
   Price 5.50 €
• Bilateral vestibular loss...
   Price 10.50 €
• The pedicled musculo-cuta...
   Price 8.50 €
• Drop weld thermal injurie...
   Price 8.50 €
• Soft palate ventilation: ...
   Price 14.00 €
• Lateral fixation of the v...
   Price 8.50 €
• Air rifle pellet injury t...
   Price 5.50 €
• Invasive cholesteatoma in...
   Price 10.50 €
• Hearing aid : practical a...
   Price 8.50 €
• Study of the supra-glotti...
   Price 10.50 €
• Nasal polyposis: long ter...
   Price 10.50 €
• Solitary myofibroma of th...
   Price 5.50 €
• Reinforcing tympanoplasty...
   Price 10.50 €
• Clinical Practice Guideli...
   Price 12.00 €
• Cytokines profile in cyst...
   Price 10.50 €
• Late metastasis from rena...
   Price 8.50 €
• Arteriovenous haemangioma...
   Price 8.50 €
• Callas or the trajectory ...
   Price 10.50 €
• The relevance of Choukrou...
   Price 10.50 €
• Laryngeal sarcoidosis: Ca...
   Price 5.50 €
• Aberrant internal carotid...
   Price 5.50 €
• Airbag and hearing loss: ...
   Price 8.50 €
• Metastatic angiosarcoma t...
   Price 5.50 €
• Evaluation of the primary...
   Price 5.50 €
• A new case of osseointegr...
   Price 12.50 €
• Multiple intracranial epi...
   Price 14.00 €
• Validation of a clinical ...
   Price 10.50 €
• Prevalence of and risk fa...
   Price 10.50 €
• Evolution of voice assess...
   Price 10.50 €
• Efficacy of voice therapy...
   Price 10.50 €
• Notes on voice and speech...
   Price 8.50 €
• Acute acoustic trauma, a ...
   Price 12.00 €
• Aspects of voice quality ...
   Price 5.50 €
• Perilymphatic Gusher as a...
   Price 10.50 €
• Usher type I syndrome in ...
   Price 10.50 €
• Quality of life evaluatio...
   Price 10.50 €

Total Order 363.50 €

contents
2019
   N# 1 |
2018
   N# 1 | 2 | 3 | 4 | 5 |
2017
   N# 1 | 2 | 3 | 4 | 5 |
2016
   N# 1 | 2 | 3 | 4 | 5 |
2015
   N# 1 | 2 | 3 | 4 | 5 |
2014
   N# 1 | 2 | 3 | 4 | 5 |
2013
   N# 1 | 2 | 3 | 4 | 5 |
2012
   N# 1 | 2 | 3 | 4 | 5 |
2011
   N# 1 | 2 | 3 | 4 | 5 |
2010
   N# 1 | 2 | 3 | 4 | 5 |
2009
   N# 1 | 2 | 3 | 4 | 5 |
2008
   N# 1 | 2 | 3 | 4 | 5 |
2007
   N# 1 | 2 | 3 | 4 | 5 |
2006
   N# 1 | 2 | 3 | 4 | 5 |
2005
   N# | 1 | 2 | 3 | 4 | 5 |
2004
   N# 1 | 2 | 3 | 4 | 5 |
2003
   N# 1 | 2 | 3 | 4 | 5 |
2002
   N# 1 | 2 | 3 | 4 | 5 |
2001
   N# 1 | 2 | 3 | 4 | 5 |
2000
   N# | 1 | 2 | 3 | 4 | 5 |
1999
   N# 1 | 2 | 3 | 4 | 5 |
1998
   N# 1 | 2 | 3 | 5 |
1997
   N# 1 | 2 | 3 | 4 | 5 |
1996
   N# 4 | 5 |

Click on the number of the review to see the content
Teaching bulletin CME
List of all teaching bulletins CME.
Editor reading committee
Editor reading committee.
To publish...
Instructions for authors
Archives Press and Books
Select of books and press articles.
Mailing list
News information letter.
Subscription prices


If you wish to adjust the size of the displayed characters, click in the high menu on "Your account" and choose the desired size.



  Contents > Previous page > Article detail print Order
o Issue N# 1 - 2016 o

RHINOLOGY

Efficacy of nasal irrigation with 2.2% hypertonic seawater in the treatment of chronic rhinosinusitis in adults


Authors : Strnad P, Skoupá J, HornÍk P, Cimrová H, Cerná V. (Prague)

Ref. : Rev Laryngol Otol Rhinol. 2016;137,1:3-10.

Article published in english
Downloadable PDF document english



Summary : Objective: To evaluate the efficacy and the tolerance of nasal irrigation with 2.2% hypertonic seawater in the treatment of chronic rhinosinusitis (CRS) in adults either used as mono­therapy, or in combination with intranasal corticosteroids. Method: In this prospective, open-label, multicenter controlled trial, 238 patients diagnosed with CRS were randomly assigned to three groups: group 1 with intranasal corticosteroids (steroid), group 2 with nasal irrigation with hypertonic seawater (seawater) and group 3 with a treatment combining intranasal corticosteroids at lower dose and seawater (steroid+seawater). Nasal index score (NIS), patient health status, intranasal corticosteroids intake, tolerance were assessed at baseline, week 2 and 6, and satisfaction at week 6. Results: NIS was significantly improved in group 2 (seawater) and group 3 (steroid+seawater) at week 2 (p< 0.001 in both groups) and week 6 (p< 0.0001 in both groups) compared to group 1 (steroid), along with a significant decrease of intranasal corticosteroids (p < 0.0001). Patient health status improved in group 2 and group 3 at week 2 (p= 0.1040 and p< 0.001 respectively) compa­red to control (steroid), and this improvement was significantly greater in both groups at week 6 compared to steroid group (p< 0.0001). Conclusion: Hypertonic nasal irrigation is an effective treatment for CRS in adults. It significantly improved nasal symptoms and allowed a signi­fi­cant decrease of intranasal corticosteroids use while improving patient health status. Nasal irrigation with 2.2% hypertonic seawater could therefore be considered as first-line treatment for CRS, either as monotherapy or in combination with lower dosage of intranasal corticosteroids.

Price : 15.00 €      order
|


Subscribe online - Pay by credit card!


© Copyright 1999-2024 - Revue de Laryngologie   Réalisation - Hébergement ELIDEE